The structure of homoschatoline and subsessiline / by 433140 Hasegawa, M., Maria Sojo

Ergosterone-coupled Triazol molecules trigger mitochondrial dysfunction, oxidative stress, and acidocalcisomal Ca2+ release in Leishmania mexicana promastigotes by Figarella K, Marsiccobetre S, Arocha I, Colina W, Hasegawa M, Rodriguez M, Rodriguez-Acosta A, Duszenko M, Benaim G, Uzcategui NL

Get full text

Recombinant Sendai virus vector to evaluate vector distribution in a large animal model of lung gene transfer by McLachlan, G, Griesenbach, U, Owaki, T, Hillery, L, Williams, J, Tsugumine, S, Boyd, C, Gill, D, Hasegawa, M, Alton, E, Collie, D

Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy by Hyde, S, Alton, E, Boyd, A, Davies, JC, Davies, LA, Gill, DR, Griesenbach, U, Hasegawa, M, Inoue, M, Pringle, IA, Sumner-Jones, SG

Recombinant Sendai virus vector to evaluate vector distribution in a large animal model of lung gene transfer by McLachlan, G, Griesenbach, U, Owaki, T, Hillery, L, Williams, J, Zhu, Y, Boyd, C, Gill, D, Hasegawa, M, Alton, E, Collie, D

Identification of the KDM2/7 histone lysine demethylase subfamily inhibitor and its antiproliferative activity. by Suzuki, T, Ozasa, H, Itoh, Y, Zhan, P, Sawada, H, Mino, K, Walport, L, Ohkubo, R, Kawamura, A, Yonezawa, M, Tsukada, Y, Tumber, A, Nakagawa, H, Hasegawa, M, Sasaki, R, Mizukami, T, Schofield, C, Miyata, N

Preparation for a first-in-man lentivirus trial in cystic fibrosis patients by Griesenbach, U, Alton, E, Beekman, J, Boyd, C, Davies, J, Davies, L, Dekkers, J, Gill, D, Hasegawa, M, Higgins, T, Hironaka, T, Inoue, M, Hyde, S, Innes, A, Pringle, I, Pytel, K, Sumner-Jones, S, Tsugumine, S, Wasowicz, M

ASSESSMENT OF F/HN-PSEUDOTYPED LENTIVIRUS IN A CLINICALLY RELEVANT VECTOR FOR LUNG GENE THERAPY by Griesenbach, U, Inoue, M, Meng, C, Farley, R, Chan, M, Newman, N, Brum, A, Kerton, A, Shoemark, A, Boyd, C, Davies, J, Higgins, T, Gill, DR, Hyde, S, Innes, A, Porteous, D, Hasegawa, M, Alton, E

Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy. by Griesenbach, U, Inoue, M, Meng, C, Farley, R, Chan, M, Newman, N, Brum, A, You, J, Kerton, A, Shoemark, A, Boyd, A, Davies, J, Higgins, T, Gill, DR, Hyde, S, Innes, J, Porteous, D, Hasegawa, M, Alton, E

ASSESSMENT OF F/HN-PSEUDOTYPED LENTIVIRUS AS A CLINICALLY RELEVANT VECTOR FOR LUNG GENE THERAPY by Griesenbach, U, Inoue, M, Meng, C, Farley, R, Chan, M, Newman, N, Brum, A, You, J, Kerton, A, Shoemark, A, Boyd, A, Davies, J, Higgins, T, Gill, DR, Hyde, S, Innes, J, Porteous, D, Hasegawa, M, Alton, E

The use of carboxymethylcellulose gel to increase non-viral gene transfer in mouse airways. by Griesenbach, U, Meng, C, Farley, R, Wasowicz, M, Munkonge, F, Chan, M, Stoneham, C, Sumner-Jones, S, Pringle, I, Gill, DR, Hyde, S, Stevenson, B, Holder, E, Ban, H, Hasegawa, M, Cheng, S, Scheule, R, Sinn, P, McCray, P, Alton, E

Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vec... by Hara, H, Hara, H, Hironaka, T, Inoue, M, Iida, A, Shu, T, Hasegawa, M, Nagai, Y, Falsey, A, Kamali, A, Anzala, O, Sanders, E, Karita, E, Mwananyanda, L, Vasan, S, Lombardo, A, Parks, C, Sayeed, E, Krebs, M, Cormier, E, Ackland, J, Price, M, Excler, J

Sendai virus-mediated CFTR gene transfer to the airway epithelium. by Ferrari, S, Griesenbach, U, Iida, A, Farley, R, Wright, A, Zhu, J, Munkonge, F, Smith, SN, You, J, Ban, H, Inoue, M, Chan, M, Singh, C, Verdon, B, Argent, B, Wainwright, B, Jeffery, P, Geddes, D, Porteous, D, Hyde, S, Gray, M, Hasegawa, M, Alton, E

ECW/EBW heating and current drive experiment results and prospects for CW operation in QUEST by Idei, H, Zushi, H, Hanada, K, Kalinnikova, E, Nakamura, K, Fujisawa, A, Nagashima, Y, Hasegawa, M, Matsuoka, K, Kariya, T, Imai, T, Minami, R, Yoshida, N, Sakamoto, M, Watanabe, H, Tokunaga, K, Ejiri, A, Sakaguchi, M, Ishiguro, M, Tashima, S, Fukuyama, A, Igami, H, Kubo, S, Isobe, M, Nagaoka, K

First Season QUIET Observations: Measurements of CMB Polarization Power Spectra at 43 GHz in the Multipole Range 25 <= ell <= 475 by Collaboration, QUIET, Bischoff, C, Brizius, A, Buder, I, Chinone, Y, Cleary, K, Dumoulin, R, Kusaka, A, Monsalve, R, Næss, S, Newburgh, L, Reeves, R, Smith, K, Wehus, I, Zuntz, J, Zwart, J, Bronfman, L, Bustos, R, Church, SE, Dickinson, C, Eriksen, H, Ferreira, P, Gaier, T, Gundersen, J, Hasegawa, M

First season quiet observations: Measurements of cosmic microwave background polarization power spectra at 43 GHz in the multipole range 25 ≤ ℓ ≤ 475 by Bischoff, C, Brizius, A, Buder, I, Chinone, Y, Cleary, K, Dumoulin, R, Kusaka, A, Monsalve, R, Næss, S, Newburgh, L, Reeves, R, Smith, K, Wehus, I, Zuntz, J, Zwart, J, Bronfman, L, Bustos, R, Church, SE, Dickinson, C, Eriksen, H, Ferreira, P, Gaier, T, Gundersen, J, Hasegawa, M, Hazumi, M

THE Q/U IMAGING EXPERIMENT INSTRUMENT by Bischoff, C, Brizius, A, Buder, I, Chinone, Y, Cleary, K, Dumoulin, R, Kusaka, A, Monsalve, R, Naess, S, Newburgh, L, Nixon, G, Reeves, R, Smith, K, Vanderlinde, K, Wehus, I, Bogdan, M, Bustos, R, Church, SE, Davis, R, Dickinson, C, Eriksen, H, Gaier, T, Gundersen, J, Hasegawa, M, Hazumi, M

SECOND SEASON QUIET OBSERVATIONS: MEASUREMENTS OF THE COSMIC MICROWAVE BACKGROUND POLARIZATION POWER SPECTRUM AT 95 GHz by Araujo, D, Bischoff, C, Brizius, A, Buder, I, Chinone, Y, Cleary, K, Dumoulin, R, Kusaka, A, Monsalve, R, Kaess, S, Newburgh, L, Reeves, R, Wehus, I, Zwart, J, Bronfman, L, Bustos, R, Church, SE, Dickinson, C, Eriksen, H, Gaier, T, Gundersen, J, Hasegawa, M, Hazumi, M, Huffenberger, K, Ishidoshiro, K

Moving lentiviral-based gene therapy into a first-in-man CF trial by Griesenbach, D, Alton, E, Beekman, J, Boyd, A, Chan, M, Davies, J, Davies, L, Davidson, H, Dekkers, F, Gea-Sorli, S, Gill, D, Hasegawa, M, Higgins, T, Hyndman, L, McLachlan, G, Inoue, M, Hyde, S, Moran, C, Meng, C, Paul-Smith, M, Pringle, I, Pytel, K, Rodriguez-Martinez, A, Stevenson, B, Tsugumine, S

Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis. by Alton, E, Beekman, J, Boyd, A, Brand, J, Carlon, M, Connolly, M, Chan, M, Conlon, S, Davidson, H, Davies, J, Davies, L, Dekkers, J, Doherty, A, Gea-Sorli, S, Gill, D, Griesenbach, U, Hasegawa, M, Higgins, T, Hironaka, T, Hyndman, L, McLachlan, G, Inoue, M, Hyde, S, Innes, J, Maher, T, Moran, C, Meng, C, Paul-Smith, M, Pringle, I, Pytel, K, Rodriguez-Martinez, A, Schmidt, A, Stevenson, B, Sumner-Jones, S, Toshner, R, Tsugumine, S, Wasowicz, M, Zhu, J